Skip to content

Food and Drug Recall.org

The Latest Food & Drug Recall and Safety News

FDA approves Zaltrap for metastatic colorectal cancer

August 4, 2012Drug Recalls & Safety Notices, Drug Safety Information Podcasts, Food & Drug Recalls, Food Safety Newsadmin

The U.S. Food and Drug Administration today approved Zaltrap (ziv-aflibercept) for use in combination with a FOLFIRI (folinic acid, fluorouracil and irinotecan) chemotherapy regimen to treat adults with colorectal cancer.

Post navigation

← Busch’s Fresh Food Market Voluntarily Recalls Deli Products Containing Peeled Whole Yellow Onions Covidien Implements a Voluntary Recall of Certain Lots of Shiley Adult Tracheostomy Tubes →
Proudly powered by WordPress